The purpose of this study is to demonstrate the efficacy of implementing the enhanced recovery after surgery (ERAS) pathway in a prospective manner to patients undergoing surgical treatment for extremity sarcoma.
Specifically, the focus of this study will be regarding the administration of a perioperative non-narcotic, multimodal pain management pathway. Primary endpoints collected with be short-term patient reported outcomes (pain scores \[PROMIS\] and \[QoR-15\]), limb function scores \[MSTS\], and key clinical outcomes (hospital length of stay, opioid requirements/prescribing data and perioperative complications).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
120
Undergo an enhanced recovery after surgery program
Vanderbilt University Medical Center
Nashville, Tennessee, United States
RECRUITINGPain scores
Measured by Quality of Recovery questionnaire (QoR-15) scale = 0-10 (0=none of the time and 10 = all of the time)
Time frame: 3 months
Pain scores
Measured by Patient-Reported Outcomes Measurement Information System (PROMIS-29 Profile v2.0) Score 1-5 (1 being worst and 5 being best)
Time frame: 3 months
Limb function
Measured by Musculoskeletal Tumor Society scoring system (MSTS) scored from 0-5 (5 being best and 0 being worst)
Time frame: 3 months
Clinical outcomes - length of hospital stay
Measured by the number of days in the hospital
Time frame: 3 months
Clinical outcomes - opioid requirements
Measured by the amount of opioids consumed
Time frame: 3 months
Clinical outcomes - perioperative complications (e.g. wound complications and 30-day readmission)
Measured by the number of perioperative complications reported
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.